Article
Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Archives of internal medicine - 27 Sept 2004
Bank Ivan, Libourel Eduard J, Middeldorp Saskia, Van Pampus Elisabeth C M, Koopman Maria M W, Hamulyák Karly, Prins Martin H, Van Der Meer Jan, Büller Harry R
Abstract excerpt
BACKGROUND: The prothrombin 20210A mutation has been associated with an increased risk of venous thromboembolism (VTE). Its relationship with arterial disease and pregnancy-related complications is, however, still uncertain. The aim of this study was to estimate the incidences of first venous and arterial thrombotic events and pregnancy-related complications in relatives of patients with the mutation. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.